{"schema_version":"secwatch.filing_event.v1","accession":"0000877860-23-000087","form_type":"8-K","ticker":"NHI","cik":"0000877860","company_name":"NATIONAL HEALTH INVESTORS INC","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.847270+00:00","generated_at":"2026-06-12T03:24:35.897662+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NHI reports Q2 net income $0.92/share, cuts full-year Normalized FFO guidance","bullets":["Net income per diluted share $0.92 (vs $0.47); NAREIT FFO $1.05 (vs $0.71); Normalized FFO $1.06 (vs $1.27).","Normalized FAD Q2 $44.6M (vs $56.3M); six-month $92.3M (vs $109.0M).","FY2023 Normalized FFO guidance cut to $4.31-$4.35 from $4.37-$4.42; FAD guidance cut to $185-$186.8M from $186.3-$188.9M.","Sold six properties in Q2 for net proceeds ~$39.1M; one more in Q3 for ~$2.9M.","Net debt to adj. EBITDA 4.6x; $196M drawn on $700M revolver; new $200M term loan placed."],"urls":{"canonical":"https://secwatch.observer/filing/0000877860-23-000087","json":"https://secwatch.observer/filing/0000877860-23-000087.json","markdown":"https://secwatch.observer/filing/0000877860-23-000087.md","text":"https://secwatch.observer/filing/0000877860-23-000087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/877860/000087786023000087/0000877860-23-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/877860/000087786023000087/nhi-20230808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T03:24:35.897662+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e82b4a6e746360052e26d3956ef60f7ff765d3c3","claim":"NATIONAL HEALTH INVESTORS INC reported three and six months ended June 30, 2023 results: EPS Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2023 was $0.. Guidance reaffirmed.","evidence_excerpt":"NHI Announces Second Quarter 2023 Results MURFREESBORO, Tenn. – (August 8, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/877860/000087786023000087/0000877860-23-000087-index.htm","confidence":0.8,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and six months ended June 30, 2023"},{"label":"EPS","value":"Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2023 was $0."},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ff1579dc8c2c028be6ff0db6a2d39edf65a8e8d4","claim":"NATIONAL HEALTH INVESTORS INC reported 2023 results: EPS Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42. Guidance lowered.","evidence_excerpt":"NHI is revising its 2023 annual guidance range for Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42 and is revising Normalized FAD to a range of $185.0 million - $186.8 million from $186.3 million - $188.9 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/877860/000087786023000087/0000877860-23-000087-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"2023"},{"label":"EPS","value":"Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}